About this event

ISPE 2026 Annual Meeting & Expo (International Society for Pharmaceutical Engineering) — Deep Buyer & Attendee Research Brief

Event Summary (from official source)

Event: 2026 ISPE Annual Meeting & Expo
Dates: 18 - 21 Oct 2026
Venue/Location: Washington, DC, United States and Virtual

Why this event matters for pharma buyers (high-level positioning)

The 2026 ISPE Annual Meeting & Expo is positioned as a high-signal gathering of pharmaceutical and biopharmaceutical professionals “from all levels of industry” for industry-critical technical discussions. The program spans sustainability, operations, supply chain, facilities, production systems, equipment, information systems, product development, quality systems, regulatory guidance, and broader industry innovations. In addition, the Expo Hall is emphasized as a central networking and technology discovery point where attendees engage directly with industry leaders, exhibitors, and service providers.

1️⃣ Who attends (BUYERS / ATTENDEES)

This event is not limited to one attendee category. Based on the official overview, it includes pharmaceutical and biopharmaceutical professionals across multiple seniority tiers, alongside global regulatory agencies. We should treat the “buyers” segment as decision-makers and influencers who have responsibility for technical strategy, compliance, quality systems, facilities and equipment, supply chain readiness, and digital/data transformation in regulated manufacturing environments.

Primary buyer/attendee groups likely to show up:

• Drug manufacturing and biopharmaceutical operations leaders involved in facilities, production systems, and manufacturing execution strategy.
• Quality systems and regulatory-facing professionals who shape how organizations implement quality standards, validation expectations, and regulatory guidance.
• Supply chain and operations professionals focused on operational reliability, traceability, and end-to-end readiness in regulated environments.
• Technology and information systems stakeholders connected to “Digital, Data, and Decision Integrity” themes (e.g., integrity of digital decisions and compliance-aligned data practices).
• Equipment and systems specialists tied to production equipment, automation enablement, and supporting technology ecosystems.
• Regulatory agency participants (explicitly mentioned as “global regulatory agencies”), typically acting as authoritative stakeholders and knowledge contributors.
• Exhibitors and sponsors (the Expo Hall is positioned as expansive), bringing solutions across services, devices/equipment support, software/data enablement, consulting, and training-related offerings.

Buyer-intent note for outreach: because the agenda explicitly addresses facilities, production systems, equipment, information systems, and quality/regulatory guidance, the “best fit” targets tend to be technical leaders and program owners rather than purely commercial-only roles.

2️⃣ Where the show is happening + attendee geographic origin

Where it happens: Washington, DC, United States and Virtual.
The official page states the event is held in Washington, DC, United States with a virtual component.

Attendee geographic origin (what we can responsibly infer from official content):

• United States + international: the event explicitly frames itself as bringing together pharmaceutical and biopharmaceutical professionals “from all levels of industry,” and it references “global regulatory agencies.” This strongly indicates international representation among regulatory and industry participants.
• Virtual component broadens reach: the virtual format likely increases ability for organizations outside Washington, DC (and outside the U.S.) to participate in sessions, training, and digital networking.

Geographic targeting recommendation (practical): We would prioritize U.S.-based pharma/biopharma decision-makers and also include global stakeholders who support regulatory alignment, digital/data integrity initiatives, and manufacturing operations improvements.

3️⃣ Audience reach (Local / National / Global)

Reach type: National-to-Global (with a U.S. anchor + virtual distribution).

Reasoning: the event is physically in Washington, DC (U.S.), but it explicitly includes global regulatory agencies and global industry leadership, and it also includes a virtual participation path. Therefore, the attendee ecosystem should be treated as more than local and more than purely national.

4️⃣ Sample buyer company names (BUYERS ONLY) + Websites

Below are buyer-oriented company examples to target in your research workflow. We select these based on how they typically map to attendee focus areas such as pharmaceutical/biopharmaceutical manufacturing, quality systems, regulatory implementation, technology enablement, and digital/data integrity themes. (These are examples of likely buyer-fit organizations; the exact booth/role involvement varies by year and participation.)

Top 5 buyer-fit targets to start with: Pfizer, Roche, Novartis, Sanofi, Merck & Co. These five best cover the event’s most explicit domains: quality systems, regulatory guidance alignment, manufacturing operations/facilities, and digital/data decision integrity interests.

5️⃣ Job profiles, industries & event type

Best job profiles to target

The official overview lists topic areas including facilities, production systems, equipment, information systems, quality systems, regulatory guidance, and operations/supply chain. So we target roles with direct responsibility for these domains.

• Quality Systems Leadership: Director/VP/Head of Quality Systems, Compliance Quality, GMP Quality Systems
• Regulatory & Regulatory Guidance Owners: Regulatory Affairs Director (or Regulatory Strategy/Implementation leads)
• Facilities & Engineering Decision-Makers: Director/Head of Facilities, Engineering, Process Facilities, Engineering Compliance
• Manufacturing & Operations Program Owners: VP/Director Global Manufacturing Excellence, Operations Systems, Production Operations
• Supply Chain Quality / Operations Leaders: Director Supply Chain Quality, Quality in Supply Chain, Integrated Operations
• Information Systems / Pharma 4.0 Track Leaders: Digital Quality Manager, Data Integrity Lead, Decision Integrity Program Owner
• Equipment/Technology Adoption Leaders: Equipment Strategy Lead, Technical Excellence, Process Technology Lead
• Advanced Therapies Owners (if applicable): ATMP Manufacturing Lead, Cell Therapy Manufacturing Quality/Operations lead
• Training & Professional Development leads: where relevant to training and Continuing Education context

Event type (how we should classify it)

Event type: Pharma technical conference + expo hall technology marketplace + training/workshops + regulatory discussion forum.
The official page references continuing education, conference sessions, workshops, networking events, professional training, regulatory town hall, and an Expo Hall.

6️⃣ Estimated attendance (expected total footfall)

Estimated attendance:
The provided official text emphasizes program scope and counts such as “150 Education Hours” and “350 Education Hours” and “350” is mentioned, plus “350” and “350” appears in the snippet; however, the provided excerpt does not include a reliable “total attendance / footfall” number. We therefore leave this field blank rather than estimate.

7️⃣ Key focus areas & buyer engagement

Featured topics and education focus (from official content):

• Pharma 4.0 and the “Digital, Data, and Decision Integrity” track
• Artificial Intelligence (explicitly referenced in the page meta description)
• ATMPs (explicitly referenced in the page meta description)
• Sustainability
• Operations and Supply Chain
• Facilities and production systems
• Equipment
• Information Systems
• Quality Systems
• Regulatory guidance
• Industry innovations

How buyers will engage (practical view of the Expo Hall + sessions):

• Expo Hall as solution discovery: we expect active conversations around compliant technologies, modernization of operations, and enabling tools for quality/regulatory needs.
• Track-based learning influences buying: Pharma 4.0 / data integrity sessions typically attract data quality, digital quality, and manufacturing/IT compliance stakeholders who later validate suppliers or service partners.
• Regulatory Town Hall as influence hub: regulatory and compliance stakeholders gather for direction-setting, which often increases receptivity to solutions that support implementation.
• Workshops and professional training: these formats tend to draw practitioners and implementers who later bring buy-in internally.
• Networking events and structured education: attendees are encouraged to connect with peers and preview technologies and services—supporting both technical and commercial engagement.

8️⃣ Client-product fit review (required: we need the client website)

We can recommend the best buyer segments and the most relevant target job titles for this ISPE 2026 Annual Meeting & Expo, but we need your client product website to do the fit mapping accurately.

Please share the client website URL and we will respond with:

• Which buyer personas in pharma/biopharma operations are most likely to be in-market for your solution at this event
• Which of the event’s focus tracks/topics best match your product claims
• Which job titles to prioritize (examples: quality systems leadership, digital/data integrity owners, facilities/engineering leaders, supply chain quality leaders)
• Which industry filters to apply (based on the Apollo-style industry list you provided)
• A refined “Top buyers to target first” shortlist

Since we do not have the client website yet, we are leaving the “best buyers based on your requirement” portion empty for accuracy.

9️⃣ Suggested industry targeting (based on your provided Apollo industry list)

Using your industry list as a guide, we suggest prioritizing the following industries because they map to the event’s stated domains: pharmaceutical manufacturing operations, quality systems, facilities/equipment, information systems, and professional training.

• Pharmaceuticals (primary)
• Biotechnology (primary, for biopharma professionals)
• Health, Wellness & Fitness (secondary/adjacent when applicable to healthcare manufacturing contexts)
• Hospital & Health Care (secondary adjacency)
• Information Technology & Services (for Pharma 4.0, digital/data integrity, information systems)
• Computer Software (for compliant software, data/integrity platforms, digital quality tools)
• Industrial Automation (for equipment, production systems, automation enablement)
• Mechanical or Industrial Engineering (for facilities/engineering/equipment program ownership)
• Construction (secondary: facilities build/modernization angle when relevant)
• Events Services (only if your solution is services/event-delivered training; otherwise ignore)
• Professional Training & Coaching (secondary: where Continuing Education/training is part of the offer)
• Research (secondary adjacency for innovation-focused orgs)
• Regulated services providers angle may also map to Outsourcing/Offshoring if your client offers CDMO/consulting/support services to pharma manufacturers.

Next steps (what we recommend to move this forward)

1. Send your client product website so we can tailor the “best buyers” list to your exact solution category.
2. Confirm whether your client sells primarily toward:
• Quality systems / compliance enablement
• Pharma 4.0 / digital, data, decision integrity
• Facilities / equipment / production systems
• Supply chain & operations
• ATMP-focused manufacturing needs
3. Once we have that, we will produce a refined buyer shortlist with the highest-likelihood job titles and the tightest industry targeting from your list.

Ready when you are: please share the client website URL.